Nicholas J. Gough
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nicholas J. Gough has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Clare Smith
Palliative Care Department, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
1 shared publicationIan Judson
Division of Medicine, Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK
1 shared publicationJoy R. Ross
Palliative Care Department, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
1 shared publicationJulia Riley
Palliative Care Department, Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
1 shared publication
Latest Publications
- Open Access
- 11 December 2011
- Published by Hindawi Limited in Sarcoma
- Vol. 2011, 1-8
Symptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma
Introduction. The symptom burden and role of palliative care (PC) in patients with advanced soft tissue sarcoma (STS) are not well defined.Methods. This study retrospectively reviewed both symptoms and PC involvement in patients known to an STS referral centre who died in one calendar year.Results. 81 patients met inclusion criteria of which 27% had locally advanced disease and 73% metastases at initial referral. The median number of symptoms was slowly progressive ranging from 2 (range 0–5) before first-line chemotherapy () to 3 (range 1–6) at the time of best supportive care (BSC) decision (). Pain and dyspnoea were the commonest symptoms. Median overall survival from BSC decision was 3.4 weeks. 88% had PC involvement (either hospital, community, or both) with median time from first PC referral to death of 16 (range 0–110) weeks.Conclusions. Patients with metastatic STS have a significant symptom burden which justifies early PC referral. Pain, including neuropathic pain, is a significant problem. Dyspnoea is common, progressive and appears to be undertreated. Time from BSC decision to death is short, and prospective studies are required to determine whether this is due to overtreatment or very rapid terminal disease progression.
- 11 December 2011
- Published by Hindawi Limited in Sarcoma
- Vol. 2011, 1-8
Open AccessSymptom Burden, Survival and Palliative Care in Advanced Soft Tissue Sarcoma
Introduction. The symptom burden and role of palliative care (PC) in patients with advanced soft tissue sarcoma (STS) are not well defined.Methods. This study retrospectively reviewed both symptoms and PC involvement in patients known to an STS referral centre who died in one calendar year.Results. 81 patients met inclusion criteria of which 27% had locally advanced disease and 73% metastases at initial referral. The median number of symptoms was slowly progressive ranging from 2 (range 0–5) before first-line chemotherapy () to 3 (range 1–6) at the time of best supportive care (BSC) decision (). Pain and dyspnoea were the commonest symptoms. Median overall survival from BSC decision was 3.4 weeks. 88% had PC involvement (either hospital, community, or both) with median time from first PC referral to death of 16 (range 0–110) weeks.Conclusions. Patients with metastatic STS have a significant symptom burden which justifies early PC referral. Pain, including neuropathic pain, is a significant problem. Dyspnoea is common, progressive and appears to be undertreated. Time from BSC decision to death is short, and prospective studies are required to determine whether this is due to overtreatment or very rapid terminal disease progression.